New Halogen-Containing Drugs Approved by FDA in 2021: An Overview on Their Syntheses and Pharmaceutical Use.
Davide Benedetto TizLuana BagnoliOrnelio RosatiFrancesca MariniLuca SancinetoClaudio SantiPublished in: Molecules (Basel, Switzerland) (2022)
This review describes the recent Food and Drug Administration (FDA)-approved drugs (in the year 2021) containing at least one halogen atom (covalently bound). The structures proposed throughout this work are grouped according to their therapeutical use. Their synthesis is presented as well. The number of halogenated molecules that are reaching the market is regularly preserved, and 14 of the 50 molecules approved by the FDA in the last year contain halogens. This underlines the emergent role of halogens and, in particular, of fluorine and chlorine in the preparation of drugs for the treatment of several diseases such as viral infections, several types of cancer, cardiovascular disease, multiple sclerosis, migraine and inflammatory diseases such as vasculitis.
Keyphrases
- drug administration
- multiple sclerosis
- cardiovascular disease
- papillary thyroid
- sars cov
- type diabetes
- drinking water
- high resolution
- molecular dynamics
- metabolic syndrome
- drug induced
- positron emission tomography
- health insurance
- computed tomography
- coronary artery disease
- squamous cell
- combination therapy
- lymph node metastasis
- childhood cancer